Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Specific desensitization in 1988].

J Bousquet1, P Godard, F B Michel

  • 1Clinique des Maladies respiratoires, Hôpital Aiguelongue, Montpellier.

Presse Medicale (Paris, France : 1983)
|May 28, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Application of the WHO chronic respiratory diseases programme in Sub-Saharian Africa: problems in Senegal].

Revue des maladies respiratoires·2004
Same author

Specific immunotherapy in rhinitis and asthma.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2001
Same author

[From allergic rhinitis to sinus diseases (sinusitis/nasal polyps): epidemiologic and experimental links].

Revue des maladies respiratoires·2000
Same author

[Asthma and rhinitis medications: pregnancy precautions].

Presse medicale (Paris, France : 1983)·2000
Same author

[Corticosteroid therapy of asthma].

Presse medicale (Paris, France : 1983)·2000
Same author

[Drug allergies: a public health problem].

Bulletin de l'Academie nationale de medecine·2000
Same journal

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

Presse medicale (Paris, France : 1983)·2026
Same journal

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026
Same journal

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026
Same journal

Decision-making for clinicians.

Presse medicale (Paris, France : 1983)·2026
See all related articles

Specific desensitization, a long-standing allergy treatment, shows promise but requires careful application. Evolving allergen quality and administration techniques are key to its future success and safety in allergy management.

Area of Science:

  • Immunology and Allergy
  • Clinical Therapeutics

Context:

  • Specific desensitization has been a widely used treatment for allergies in children and adolescents for over 65 years.
  • While its scientific underpinnings have been established in the last decade, its efficacy and safety profile are under scrutiny.

Purpose:

  • To evaluate the current status, efficacy, safety, and future prospects of specific desensitization in managing allergic diseases.
  • To discuss the challenges associated with potent allergens, treatment duration, and cost-effectiveness.

Summary:

  • Desensitization is effective with appropriate methodology but potent allergens increase risks, leading to criticism regarding its efficacy/safety ratio and duration.
  • While effective for Hymenoptera venom allergy and moderate house dust mite-induced asthma, long-term or lifelong treatment may be necessary for other allergies, raising cost concerns.

Related Experiment Videos

  • Future directions include developing safer, high-quality allergens and exploring novel techniques like monoclonal or anti-idiotype antibodies.

    • Impact:

    • Highlights the need for improved allergen standardization and safer administration techniques to optimize desensitization therapy.
    • Suggests that desensitization remains indispensable for Hymenoptera allergy prevention and useful for specific asthma and other allergic conditions.
    • Indicates potential for future advancements in desensitization through biotechnological approaches, improving patient outcomes and treatment adherence.